MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics SHELTON, CT / ACCESS Newswire / May 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (t ...

There is no approved drug for Measles virus infection ... Herpesvirus infections from HSV-1, HSV-2, VZV, EBV, as well as HHV-6 have been linked to neurological damage that can eventually lead ...

According to research, primary HHV-6 infection (the virus that causes roseola) has been associated with a large number of potential complications including myocarditis, rhabdomyolysis ...

It is caused by a virus, most commonly human herpesvirus 6 (HHV-6) or, less frequently, HHV-7. The viral illness most commonly affects children between 6 months and 2 years old.

If the vaccination rates continue to decline, measles virus could become endemic ... Our other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. The Company cannot project ...

NanoViricides, Inc. (NYSE American: NNVC), (the "Company"), a leading clinical stage global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that ...